arrow
L

Lea F. Surrey

children's hospital of philadelphia
H指数:30
被引数:3,943

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current Status of Genetic Testing and Mosaic Variant Assessment in Somatic Overgrowth and Vascular Anomalies: Insights from the Cancer Genomics Consortium Working Group

体量过度增长和血管异常中基因检测及嵌合变异评估的当前状况:癌症基因组学联盟工作组见解

2026-08-190
OA
A High-Sensitivity Circulating Nucleic Acid Sequencing Assay for Assessing Treatment Response to Alectinib in a Pediatric Patient With ALK-Rearranged Non-Small Cell Lung Cancer

一种高灵敏度循环核酸测序检测方法,用于评估携带ALK重排的非小细胞肺癌儿科患者对阿来替尼的治疗反应

2026-07-010
OA
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity

PLK4抑制剂RP-1664通过双重敏感性机制在神经母细胞瘤临床前模型中显示出显著疗效

2026-06-130
OAAI
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial

Tra贝替丁和低剂量伊立替康靶向EWS::FLI1在尤因肉瘤中的作用: 1/2期试验

2026-04-160
PRE
Leveraging genomic diagnostics for prognostics and therapeutics in pediatric acute leukemia

利用基因组诊断学对儿童急性白血病的预后和治疗。

2025-11-250
OAAI
Reprogramming neuroblastoma by diet-enhanced polyamine depletion

通过饮食增强的聚胺耗竭重编程神经母细胞瘤

Nature
IF48.5
2025-09-240
OAAI
Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring

高风险神经母细胞瘤的纵向单细胞多组学图谱揭示了化疗诱导的肿瘤微环境重构

2025-04-140
OA
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
2024-07-311
OAAI
Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence
2024-05-032
PRE
Uncovering the Genetic Etiology of Inherited Bone Marrow Failure Syndromes Using a CustomDesigned Next-Generation Sequencing Panel

使用定制设计的下一代测序面板揭示遗传性骨髓衰竭综合征的遗传病因

2024-03-010
OAAI
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumor- only versus paired tumor-normal sequencing
2024-02-222
OAAI